Many of the most devastating infectious diseases are caused by RNA viruses, and Model Medicines is working on one compound to ...

Following four straight sessions of gains, Moderna (NASDAQ:MRNA) shares continued to trade higher in the premarket on Friday after the company received a tender to supply its COVID-19 vaccine in the ...

Under the agreement, 17 participating countries could order an updated version of the biotech company's mRNA Covid-19 vaccine for up to four years. The vaccine, marketed as Spikevax in Europe, was ...

Pulmonary fibrosis is a rare, chronic disease that causes scarring in the lungs, making breathing difficult for people who suffer with it. And, as University of South Florida pulmonologist Dr. Jose ...

BioNTech and Moderna COVID-19 vaccines use mRNA technology in their vaccines to protect us from the spread of the disease.

Public health experts say there could be massive implications after President Trump signed an executive order withdrawing the ...

The president announced a major AI investment project, which Oracle Chairman Larry Ellison said could be used to cure cancer.

The lack of clarity and widespread unfamiliarity about Human Metapneumovirus (HMPV) among the public and health experts has ...

Share prices of Moderna (NASDAQ: MRNA) plummeted 58% in 2024, ranking among the worst performers in the S&P 500 index. The ...

Moderna has been testing an mRNA candidate for influenza viruses like the H5 and H7 strains that are seen as pandemic threats ...

Twenty states (plus D.C.) had "very high" levels of the virus present in wastewater, an increase from 16 states the week before.